Enterocutaneous fistula
Based on the modality of treatment, historically the management of enterocutaneous fistula has been grouped into three periods. The era of antibiotics (1945-1960), the era of intensive nurse care (1960-1970) and the era of intravenous hyperalimentation (1970-1975). Schein′s modification o...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2001-01-01
|
| Series: | The Saudi Journal of Gastroenterology |
| Subjects: | |
| Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2001;volume=7;issue=2;spage=51;epage=54;aulast=Ajao |
| _version_ | 1818272345726386176 |
|---|---|
| author | Ajao Oluwole Shehri Mohammed |
| author_facet | Ajao Oluwole Shehri Mohammed |
| author_sort | Ajao Oluwole |
| collection | DOAJ |
| description | Based on the modality of treatment, historically the management of enterocutaneous fistula has been grouped into three periods. The era of antibiotics (1945-1960), the era of intensive nurse care (1960-1970) and the era of intravenous hyperalimentation (1970-1975). Schein′s modification of Sitges-Serra classification of enterocutaneous fistula is now preferred to the old classification of high-output type and low output type. A major cause of enterocutaneous fistula is technical failure. Serum level of short-turn over proteins such as albumin retinal-binding protein, thyroxin binding pre-albumin as serum transferring are predictors of mortality and spontaneous fistula closure. Immediate surgical correction of the fistula is not a priority of treatment. The control of sepsis and adequate nutrition are the two most important aspects of management. The use of somatostatin and octreotide has been shown to shorten the period of spontaneous closure of the fistula. |
| first_indexed | 2024-12-12T21:40:36Z |
| format | Article |
| id | doaj.art-d22ba69b0b7d44d3b678145bdd794809 |
| institution | Directory Open Access Journal |
| issn | 1319-3767 |
| language | English |
| last_indexed | 2024-12-12T21:40:36Z |
| publishDate | 2001-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | The Saudi Journal of Gastroenterology |
| spelling | doaj.art-d22ba69b0b7d44d3b678145bdd7948092022-12-22T00:11:04ZengWolters Kluwer Medknow PublicationsThe Saudi Journal of Gastroenterology1319-37672001-01-01725154Enterocutaneous fistulaAjao OluwoleShehri MohammedBased on the modality of treatment, historically the management of enterocutaneous fistula has been grouped into three periods. The era of antibiotics (1945-1960), the era of intensive nurse care (1960-1970) and the era of intravenous hyperalimentation (1970-1975). Schein′s modification of Sitges-Serra classification of enterocutaneous fistula is now preferred to the old classification of high-output type and low output type. A major cause of enterocutaneous fistula is technical failure. Serum level of short-turn over proteins such as albumin retinal-binding protein, thyroxin binding pre-albumin as serum transferring are predictors of mortality and spontaneous fistula closure. Immediate surgical correction of the fistula is not a priority of treatment. The control of sepsis and adequate nutrition are the two most important aspects of management. The use of somatostatin and octreotide has been shown to shorten the period of spontaneous closure of the fistula.http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2001;volume=7;issue=2;spage=51;epage=54;aulast=Ajaoentercutaeous fistulashort-turnover proteinsomatostatin and octreotide. |
| spellingShingle | Ajao Oluwole Shehri Mohammed Enterocutaneous fistula The Saudi Journal of Gastroenterology entercutaeous fistula short-turnover protein somatostatin and octreotide. |
| title | Enterocutaneous fistula |
| title_full | Enterocutaneous fistula |
| title_fullStr | Enterocutaneous fistula |
| title_full_unstemmed | Enterocutaneous fistula |
| title_short | Enterocutaneous fistula |
| title_sort | enterocutaneous fistula |
| topic | entercutaeous fistula short-turnover protein somatostatin and octreotide. |
| url | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2001;volume=7;issue=2;spage=51;epage=54;aulast=Ajao |
| work_keys_str_mv | AT ajaooluwole enterocutaneousfistula AT shehrimohammed enterocutaneousfistula |